Balyasny Asset Management »

Krystal Biotech shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $32M 257k 124.06
2023-09-30 $3.8M 33k 116.00
2023-06-30 $4.3M 37k 117.40
2023-03-31 $3.3M 41k 80.06
2022-12-31 $664k 8.4k 79.22

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Lord, Abbett & Co
Dimensional Fund Advisors
Ikarian Capital
Credit Suisse
T. Rowe Price Associates
Balyasny Asset Management
TimesSquare Capital Management
First Turn Management
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Krystal Biotech